Motilium, Generic: Price Analysis - Australia & International

Top level a general survey of the material

Domperidone, often sold under the trade name Motilium and available generically, is a dopamine receptor blocker used to reduce nausea and to speed gastric emptying. In Australia it is commonly supplied as 10 mg strength tablets. This page provides a compact reference on what domperidone is used for, how it is normally taken, essential safety pointers, typical retail housing costs in Australian dollars, in conjunction with the legal framework for supply and import.

• Active substance: domperidone
• Typical formulation: 10 mg oral tablets; liquid forms exist but may not be routinely available in Australian pharmacies
• Main effects: antiemetic action and prokinetic activity to improve gut transit

Use the navigation above or jump directly to dosing, safety, two-way communication in actions between people can shape outcomes., prices, or regulation: see Dose Delivery and Administration, Safety Measures and Measures for safety, or The cost of goods in Australia.

Use Visible signs in Clinical Care

Healthcare professionals may prescribe domperidone for a variety of clues where enhancing gastrointestinal motility or controlling nausea is desired. Typical scenarios include:

• Relief of nausea and vomiting from gastrointestinal or central causes, including some chemotherapy-related symptoms
• Treatment of symptomatic gastroparesis or delayed gastric emptying presenting with bloating, early satiety, or reflux
• Use prior to radiological studies of the upper GI tract to reduce gastric residue and improve imaging quality

Pregnant or breastfeeding patients should consult the Safety oriented considerations and Safety measures before useassessment the the section unit. Always follow the directions of a qualified prescriber and note that domperidone requires a valid prescription in Australia; see Regulatory and Status of Legal Rights.

Dosing and Administering Guidelines

The instructions below are general guidance only and do not replace individualized medical advice from your prescriber.

Administration advice

• Take tablets by mouth. They are usually recommended 15 to 30 minutes before meals to enhance gastric emptying.
• If a dose is unintentionally missed, take it when remembered unless the next dose is due soon. Do not repeat a dose in one sitting.
• Check product information for excipients such as lactose and inform your prescriber if you have related intolerances.

Usual dosing schedule patterns

• Acute nausea, vomiting or refractory hiccup
  • Adults: commonly 20 mg (two ten milligram dosage tablets) three times daily; some regimens use up to three to four times daily depending on indication and clinical judgement
  • The youth population 5 to 12 years: often 10 mg three times daily under specialist guidance
• Chronic dyspepsia or delayed gastric emptying
  • Adults: 10 mg three times daily before meals is a frequent starting regimen; dose may be tapered to the lowest effective amount
  • The child cohort 5 to 12 years: doses are reduced, commonly 5 to 10 mg given several times daily only under medical supervision

Adjustments and cautions

• Australian advice promotes using the smallest effective dose for the shortest necessary duration; adult total daily dose is generally kept at or below 30 mg unless explicitly directed by a specialist.
• The younger crowd under about 35 kg may be better managed with an oral suspension when available; some clinicians avoid tablets in small children.
• Not routinely recommended for children younger than 12 years except on specialist instruction.

Renal and hepatic issues

• Severe kidney disease can prolong elimination; a reduced dosing frequency or lower total daily dose may be required with close time sensitive monitoring.
• Moderate to severe liver impairment is a contraindication to use in many cases; consult a specialist for exceptions.

If you are uncertain about dosing, contact your doctor or pharmacist. For information on interacting medicines or cardiac risks see Drug Interaction Terminology and Safety and Protective Measures.

Best practices for the storage of files is essential for data management.

• Keep at controlled room temperature, ideally between 20 and 25 degrees C (68 to 77 degrees F), unless the product label states otherwise.
• Protect from strong heat, direct sunlight and excessive humidity. Bathrooms are not for keeping materials in storage ensures their availability for future operations..
• Store out of reach of children and animals and keep tablets in their original container until use.

Safety and Protective Measures

No-go when this treatment should not be used

• Known hypersensitivity to domperidone or any ingredient in the formulation
• Gastrointestinal hemorrhage, obstruction or perforation where stimulating motility is unsafe
• Prolactin-secreting pituitary tumors
• Moderate to severe hepatic impairment in most cases

Apply with caution.

• Patients with cardiac disease, a history of arrhythmia, or electrolyte imbalance such as low potassium or magnesium
• When combined with medicines that lengthen the QT interval or with strong CYP3A4 inhibitors; consult Drug Interaction Terminology
• Older adults and people with multiple comorbidities

Pregnancy and lactation

• Data in pregnancy are limited. Use only if a clinician determines the benefits to the mother outweigh possible dangers to the fetus.
• Small amounts of domperidone pass into breast milk. Prescribers will weigh maternal benefits versus potential infant exposure before recommending treatment while breastfeeding.

Always tell your healthcare team about all prescription, over-the-counter, and herbal products you take. If you develop new or worrying symptoms, seek medical review.

Drug Interaction Assessments

Domperidone interacts with several drug classes. Check with your prescriber or pharmacist before merging the two medications.

Drugs that may lessen prokinetic efficacy

• Anticholinergic medicines such as atropine, hyoscine and propantheline
• Medications for urinary overactivity including oxybutynin and tolterodine
• Certain antiparkinsonian antimuscarinics like procyclidine
• Opioid analgesics such as morphine and codeine can blunt motility-enhancing effects

Drugs that increase domperidone levels or cardiac risk

• Strong inhibitors of CYP3A4 including some azole antifungals (for example ketoconazole), macrolide antibiotics (for example clarithromycin), and some antiretroviral agents
• Medicines that prolong the QT interval such as certain antiarrhythmics and some antipsychotics
• Certain calcium channel blockers like verapamil and diltiazem
• Avoid grapefruit juice unless your clinician says it is safe

For cardiac risk details see the Adverse effects and Safety Protocols and Harm prevention measures portions. If you plan to start or stop any medication while taking domperidone, discuss it in dialog with your prescriber.

Secondary adverse effects

The likelihood of experiencing unfavorable effects is not the same for everyone. Below are commonly reported and less frequent reactions to be aware of.

Predictable effects

• Elevated prolactin levels which may lead to breast tenderness, milk secretion, or menstrual changes
• Decreased sexual drive in some patients

Less conspicuous and rare events

• Gastrointestinal complaints such as abdominal pain or diarrhea
• Allergic skin reactions, for example rashes or hives
• Extrapyramidal symptoms including tremor, involuntary movements or muscle stiffness; these require prompt medical assessment

Cardiac concerns

• Domperidone can prolong the QT interval and, rarely, cause ventricular arrhythmias. The risk increases with excessive dosing, social interactive engagements influence perceptions and decisions. with QT-prolonging drugs, older age, and electrolyte disturbances.

Seek fast medical care for sudden fainting, chest pain, palpitations, severe dizziness, or symptoms suggesting a serious allergic reaction. Report adverse events to your prescriber or pharmacist.

Substitutes and Similar Pharmaceuticals

Depending on diagnosis, patient factors and risk profile, clinicians may select from several other possible paths. Benchmark them against each other their typical effects and safety characteristics when discussing options with your health care provider.

• Metoclopramide (for example Maxolon) - antiemetic and prokinetic; higher propensity for movement disorders, particularly in younger patients
• Ondansetron - a 5-HT3 receptor antagonist commonly used for postoperative and chemotherapy-induced nausea; it controls nausea but does not speed gastric emptying
• Prochlorperazine - an older dopamine antagonist used for severe nausea and migraine-associated vomiting; may cause sedation and movement adverse effects
• Hyoscine hydrobromide (scopolamine) - anticholinergic agent useful for motion sickness; not a prokinetic and has anticholinergic lingering reactions

Cost, conditions that preclude use, age, comorbidities and individual response all influence the best choice. See Prices in the Australian market for approximate cost differences and Regulatory and Status Within the Legal Framework for prescription requirements.

Australia price quotes (AUD)

The prices below are indicative retail ranges in Australian currency in dollars. Actual cost depends on brand, pack size, pharmacy dispensing fees and whether the product is covered by the Pharmaceutical Benefits Scheme (PBS).

• Domperidone 10 mg strength tablets (Motilium or generic) - usually supplied privately and not commonly PBS-subsidised. Expect roughly AUD 8 to 20 for packs of 25 to 30 tablets, and around AUD 15 to 35 for larger packs up to 100 tablets.
• Metoclopramide 10 mg - some evidence are PBS-listed; private purchase prices often fall in the AUD 5 to 15 range for small to medium packs.
• Ondansetron 4 mg or 8 mg - variable by formulation and pack size; small packs commonly retail between AUD 10 and 30. Some suggestions qualify for PBS subsidy.
• Prochlorperazine 5 mg or 10 mg - typical retail prices are about AUD 6 to 15 for small to medium packs, though PBS availability varies by indication.

Notes on access and cost:

• PBS listings substantially reduce patient expense for qualifying medicines; domperidone is most often dispensed privately and may not be PBS-subsidised.
• Pharmacy dispensing fees, brand selection and available generics can change the final price. Look to an expert for help your local pharmacist for current wholesale pricing and cheaper contingency options.

Regulatory and Status in the Eyes of the Law

• Scheduling: In Australia domperidone is classified as a Schedule 4 medicine, meaning it is available by prescription only from an authorised prescriber.
• TGA recommendations: The Therapeutic Goods Administration advises prescribers to use the lowest effective dose for the shortest period, consider cardiac risk factors, and seek specialist input for children under 12 years.
• Personal importation: The TGA Personal Importation Program typically allows individuals to import up to a three month supply for personal use provided they have a valid prescription together with the shipment meets customs requirements. Regulations and border checks may change, so verify current TGA guidance before ordering overseas.
• Advertising: Direct-to-consumer advertising of prescription medicines is restricted under Australian law and also the Therapeutic Goods Advertising Code.

Only obtain prescription medicines from licensed pharmacies and prescribers. Procuring medicines from unregulated sources or using them without a prescription can be unlawful and unsafe.